Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1AIDS-related Kaposi sarcoma 1

Interventions

Zidovudine 9Interferon alpha-2 5Doxorubicin 5Vincristine 4Bleomycin 4pomalidomide 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3sargramostim 2liposomal doxorubicin 2interferon alfa-n1 2Etoposide 2Didanosine 2Biopsy 2Bevacizumab 2tocilizumab 1pembrolizumab 1halofuginone 1entinostat 1cabozantinib 1abemaciclib 1Zalcitabine 1Valganciclovir 1Therapeutics 1Sorafenib 1Psychiatric Rehabilitation 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sarcoma, Kaposi × halofuginone × Clear all
NCT00064142 2013-06-05

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡